BioStock: Abliva’s mission to become mitochondrial medicine powerhouse
Abliva’s CMO Magnus Hansson attended the 8th annual meeting of Mitochondrial Medicine – Therapeutic Development in March. The conference brings together leaders in translational mitochondrial medicine to discuss recent advances in the area of mitochondrial research and clinical development. BioStock spoke with Hansson to better understand how scientific meetings like this one fit into the company’s overall mission
Read the article at biostock.se:
Abliva’s mission to become mitochondrial medicine powerhouse - BioStock
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/